Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.

Journal of vascular and interventional radiology : JVIR - 1 May 2020

Malone Christopher D, Gibby Wendell, Tsai Richard, Kim Seung Kwon, Lancia Samantha, Akinwande Olaguoke, Ramaswamy Raja S

Abstract excerpt

PURPOSE: To evaluate outcomes of yttrium-90 radioembolization in patients with combined biphenotypic hepatocellular-cholangiocarcinoma (cHCC-CC). MATERIALS AND METHODS: A retrospective review of patients with biopsy-confirmed cHCC-CC treated with yttrium-90 radioembolization between 2012 and 2018 was performed. Twenty-two patients with cHCC-CC (mean age 65.6 y, 17 men, 5 women) underwent 29 radioembolization...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bile Duct Neoplasms
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Cholangiocarcinoma

Share to Liver Neoplasms

Share to Neoplasm Staging

Share to Radiopharmaceuticals

Share to Treatment Outcome

Source

Identifiers

PMID: 32127318
DOI: 10.1016/j.jvir.2019.09.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma.PMID 32127318Read ↗

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.Semantic proximity Read ↗

Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.Semantic proximity Read ↗

Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.Semantic proximity Read ↗

Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.Semantic proximity Read ↗

Clinical Effects and Safety of Different Transarterial Chemoembolization Methods for Bridging and Palliative Treatments in Hepatocellular CarcinomaSemantic proximity Read ↗

Clinical Outcomes of Next-Generation Microwave Thermosphere Ablation for Hepatocellular Carcinoma with Primarily Hepatitis-Related EtiologySemantic proximity Read ↗

Association of PI3K Pathway Mutations with Early Positron-Emission Tomography/CT Imaging Response after Radioembolization for Breast Cancer Liver Metastases: Results of a Single-Center Retrospective Pilot Study.Semantic proximity Read ↗

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathologySemantic proximity Read ↗

Endobiliary Radiofrequency Ablation: Principles, Technique, and Evidence in CholangiocarcinomaSemantic proximity Read ↗

Boron Neutron Capture Therapy Eliminates Radioresistant Liver Cancer Cells by Targeting DNA Damage and Repair ResponsesSemantic proximity Read ↗

Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.Semantic proximity Read ↗

Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.